Claire Catherinet

    Analyst, Crossover Strategy

    Claire joined us in February 2021 as an analyst with the Crossover team. Prior to joining Sofinnova Partners, Claire was an analyst on the Life Sciences team at Andera Partners, where she identified and invested in biotech and medtech companies.

    Claire has a Ph.D. in Hemato-Oncology from Paris Diderot University, which she carried out at the Institut Curie, working on elucidating signaling pathways involved in the activity of leukemic-initiating cells in T cell acute lymphoblastic leukemia (T-ALL).

    She also holds an M.Sc. from the French engineering school Agrocampus Ouest and a degree in Biopharmaceutical Management from ESCP Business School. Her research has been published in journals such as Nature Communications and Cancer Cell.



    Welcome to our new website – a fresh look that represents a new SofinnovaFind out more